+Compare
IMMP
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
169.57M

IMMP Immutep Limited Forecast, Technical & Fundamental Analysis

a developer of anti-cancer therapeutics

Industry Biotechnology
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Sorrento Therapeutics, Inc. (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.18B. The market cap for tickers in the group ranges from 402 to 410.6B. NVO holds the highest valuation in this group at 410.6B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -5%. For the same Industry, the average monthly price growth was 32%, and the average quarterly price growth was 32%. SKYED experienced the highest price growth at 81%, while SEEL experienced the biggest fall at -82%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was 80% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 87
Price Growth Rating: 69
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
A.I. Advisor
published Earnings

IMMP is expected to report earnings to rise 5.06% to -15 cents per share on August 30

Immutep Limited IMMP Stock Earnings Reports
Q2'22
Est.
$-0.16
Q2'23
Est.
$-0.15
Q4'22
Beat
by $0.01
The last earnings report on August 29 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 79.04K shares outstanding, the current market capitalization sits at 169.57M.
A.I. Advisor
published General Information

General Information

a developer of anti-cancer therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
24
Web
https://www.immutep.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOTNX1.52N/A
N/A
MassMutual Fundamental Growth R3
AIVGX15.18N/A
N/A
American Funds International Vntg F-3
JFAMX26.93N/A
N/A
JPMorgan Emerging Markets Equity A
RTDCX15.48-0.02
-0.13%
Russell Inv Multifactor US Equity C
PMVFX20.40-0.09
-0.44%
PGIM Quant Solutions Mid-Cap Val R4

IMMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMMP has been loosely correlated with XBIT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IMMP jumps, then XBIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
+0.51%
XBIT - IMMP
34%
Loosely correlated
-4.39%
CRVS - IMMP
32%
Poorly correlated
+0.66%
GBIO - IMMP
31%
Poorly correlated
-4.06%
XFOR - IMMP
31%
Poorly correlated
-0.95%
ARCT - IMMP
31%
Poorly correlated
+1.19%
More

Groups containing IMMP

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMP
1D Price
Change %
IMMP100%
+0.51%
australia
(undefined stocks)
10%
Poorly correlated
+0.03%
biotechnology
(undefined stocks)
3%
Poorly correlated
-0.81%
cancer
(undefined stocks)
1%
Poorly correlated
-1.34%
drugs
(undefined stocks)
1%
Poorly correlated
-0.89%
therapeutics
(undefined stocks)
-1%
Poorly correlated
-1.01%